NEW YORK (GenomeWeb) – In a recent filing with the US Securities and Exchange Commission, CareDx said it intends to offer for sale 3 million of its shares of common stock.

The firm has not yet priced its shares but said the proposed maximum offering price will be $2.72 per share. The proposed maximum aggregate offering price is about $9.4 million, it added.

The firm has also granted the unnamed underwriters a 30-day option to purchase up to 450,000 additional shares of common stock at the public offering price to cover any over-allotments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.